Cullinan Therapeutics, Inc. earnings per share and revenue

CGEM earnings per share for the last quarter are -0.54 USD whereas the estimation was -0.96 USD which accounts for 43.83% surprise. Företagets omsättning för samma period uppgår till 0.00 USD trots den uppskattade siffran 0.00 USD. Estimated earnings per share for the next quarter are -0.99 USD, and revenue is expected to reach 0.00 USD. Also watch annual changes over time to get a bigger picture of CGEM earnings per share and revenue dynamics.